Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - atracurium besilate, quantity: 25 mg - injection - excipient ingredients: benzenesulfonic acid; water for injections - atracurium besylate injection is indicated as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection - excipient ingredients: water for injections; benzenesulfonic acid - atracurium besylate is indicated as an adjunct to general anesthesia, to facilitate endotrachael intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cisatracurium besilate, quantity: 14.07 mg (equivalent: cisatracurium, qty 10.5 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cisatracurium besilate, quantity: 13.4 mg (equivalent: cisatracurium, qty 10 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

Egyesült Államok - angol - NLM (National Library of Medicine)

fresenius kabi usa, llc - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium 2 mg in 1 ml - cisatracurium besylate injection is an intermediate-onset/intermediate-duration neuromuscular blocking agent indicated for inpatients and outpatients as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation in the icu. cisatracurium is contraindicated in patients with known hypersensitivity to the product and its components.  the 10 ml multiple dose vials of cisatracurium is contraindicated for use in premature infants because the formulation contains benzyl alcohol (see warnings and  precautions,  pediatric use ).

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cisatracurium besilate, quantity: 6.7 mg/ml (equivalent: cisatracurium, qty 5 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - nimbex injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - other conditions: protect from light. nimbex injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - nimbex injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as adjunct to general anaesthesia, or sedation in the intensive care unit.

Kanada - angol - Health Canada

accord healthcare inc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents

Egyesült Államok - angol - NLM (National Library of Medicine)

sagent pharmaceuticals - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate injection is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.